Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Napco Security Technologies, Inc. of Class Action Lawsuit and Upcoming Deadlines - NSSC
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Fortress Energy Inc. - NFE
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Redwire Corporation - RDW
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caleres, Inc. - CAL
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hallador Energy Company - HNRG
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reddit, Inc. - RDDT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EchoStar Corporation - SATS
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Laser Photonics Corporation - LASE
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brown-Forman Corporation - BF-B; BF-A
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Digimarc Corporation of Class Action Lawsuit and Upcoming Deadlines - DMRC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming Deadlines - OGN
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadlines - RKT
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines - CODI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - URGN
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in DoubleVerify Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - DV
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Krispy Kreme, Inc. of Class Action Lawsuit and Upcoming Deadlines - DNUT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coinbase Global, Inc.- COIN
-
Pomerantz Law Firm Announces the Filing of a Class Action Against NET Power Inc. and Certain Officers – NPWR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
-
ZA Miner Introduces Intelligent Cloud Mining Platform for 2025, Capitalizing on Bitcoin Halving Momentum and Market Growth
-
Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
-
Seventh Presale Phase: Bitcoin Solaris Nears Public Launch with 10,000 TPS and 21M Supply Cap
-
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autol
-
XRP News: Vaultro Finance Presale on XRP ledger Skyrockets Past 50%, As Investors Race to Own $VLT Token
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
-
Prix Fitzgerald 2025 Laureate Announced at Hôtel Belles Rives
-
Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme
-
AIXA Miner has opened a new chapter in DOGE, LTC, and BTC AI cloud mining with the license
-
ZA Miner Rolls Out All-in-One Cloud Mining Solution with Free Trial and Steady Daily Earnings
-
Nimanode Surpasses Crypto Presales, Eyes 10X Growth Post-Launch as Major Investors Flock to the XRP DeFi Landscape
-
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
-
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
-
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
-
PFMCrypto's "1-Day Mining Contract" Sales Surge 76% – $1 Million Giveaway Ignites Community Buzz
-
UPDATE -- Ready Capital Corporation Declares Second Quarter 2025 Dividends
